×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CAI – caris life sciences, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CAI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/24
08:00 am
cai
Caris Life Sciences: Stronger Fundamentals, Same Conclusion [Seeking Alpha]
Low
Report
Caris Life Sciences: Stronger Fundamentals, Same Conclusion [Seeking Alpha]
12/22
08:02 am
cai
Caris Life Sciences (NASDAQ:CAI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $28.00 to $30.00. They now have a "hold" rating on the stock.
Low
Report
Caris Life Sciences (NASDAQ:CAI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $28.00 to $30.00. They now have a "hold" rating on the stock.
12/19
08:30 am
cai
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
Low
Report
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
12/17
04:32 pm
cai
Caris Life Sciences (NASDAQ:CAI) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Caris Life Sciences (NASDAQ:CAI) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
12/16
08:56 am
cai
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need [Yahoo! Finance]
Medium
Report
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need [Yahoo! Finance]
12/16
08:30 am
cai
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
Low
Report
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
12/11
04:16 pm
cai
Caris Life Sciences (NASDAQ:CAI) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Caris Life Sciences (NASDAQ:CAI) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
12/10
06:24 pm
cai
ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification [Yahoo! Finance]
Low
Report
ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification [Yahoo! Finance]
Date
Time
Symbol
Headline
Impact
12/12
07:39 pm
cai
Form 4 Caris Life Sciences, For: Dec 11 Filed by: Power Luke Thomas
Low
Report
Form 4 Caris Life Sciences, For: Dec 11 Filed by: Power Luke Thomas
12/12
06:23 pm
cai
Form 4 Caris Life Sciences, For: Dec 10 Filed by: Brille Brian J
Low
Report
Form 4 Caris Life Sciences, For: Dec 10 Filed by: Brille Brian J
12/11
04:27 pm
cai
Form 144 Caris Life Sciences, Filed by: Power Luke Thomas
Low
Report
Form 144 Caris Life Sciences, Filed by: Power Luke Thomas
11/10
08:13 am
cai
Form 4 Caris Life Sciences, For: Nov 07 Filed by: Denton John Russel
Medium
Report
Form 4 Caris Life Sciences, For: Nov 07 Filed by: Denton John Russel
11/10
08:11 am
cai
Form 4 Caris Life Sciences, For: Nov 07 Filed by: Spetzler David Baxley
Medium
Report
Form 4 Caris Life Sciences, For: Nov 07 Filed by: Spetzler David Baxley
11/5
05:02 pm
cai
Form 10-Q Caris Life Sciences, For: Sep 30
High
Report
Form 10-Q Caris Life Sciences, For: Sep 30
11/5
04:18 pm
cai
Form 8-K Caris Life Sciences, For: Nov 05
High
Report
Form 8-K Caris Life Sciences, For: Nov 05
10/30
04:21 pm
cai
Form 8-K Caris Life Sciences, For: Oct 30
Medium
Report
Form 8-K Caris Life Sciences, For: Oct 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 4 CAI International, Inc. For: Mar 02 Filed by: HALLAHAN DANIEL JAMES
10.9%
12/16 CAI International, Inc. Announces Review of Strategic Alternatives 8.6%
4/7 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 3.9%
4/29 Form 10-K/A CAI International, Inc. For: Dec 31 3.8%
8/23 Form SC 13D CAI International, Inc. Filed by: Weiss Asset Management LP 3.1%
10/21 CAI International Inc (NYSE: CAI) had its "sell" rating re-affirmed by analysts at Wells Fargo & Co. 2.6%
2/3 Form SC 13D/A CAI International, Inc. Filed by: Weiss Asset Management LP 2.5%
8/5 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.5%
10/9 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 2.2%
9/10 Form SC 13G/A CAI International, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 1.8%
12/16 CAI International, Inc. Announces Review of Strategic Alternatives 8.6%
4/7 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 3.9%
4/29 Form 10-K/A CAI International, Inc. For: Dec 31 3.8%
8/23 Form SC 13D CAI International, Inc. Filed by: Weiss Asset Management LP 3.1%
10/21 CAI International Inc (NYSE: CAI) had its "sell" rating re-affirmed by analysts at Wells Fargo & Co. 2.6%
2/3 Form SC 13D/A CAI International, Inc. Filed by: Weiss Asset Management LP 2.5%
8/5 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.5%
10/9 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 2.2%
9/10 Form SC 13G/A CAI International, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 1.8%
TOP News Decliners
3/16
CAI Logistics’ Flatbed Team Named to Supply & Demand Chain Executive’s 2020 List of Pros to Know
-18.5%
3/11 CAI International Inc (NYSE: CAI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. -17.1%
8/7 Form 10-Q CAI International, Inc. For: Jun 30 -5.9%
3/4 Form 4 CAI International, Inc. For: Mar 02 Filed by: Cutino Camille -5.8%
2/21 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.7%
3/5 Q4/2019 12/31/2019 EPS 0.540 ZacksConsensus N/A ActVsEst N/A - N/A -3.5%
2/24 Form 4 CAI International, Inc. For: Feb 13 Filed by: PAGE TIMOTHY B -3.4%
5/31 CAI International Inc (NYSE: CAI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -3.3%
10/29 CAI International, Inc. Reports Results for the Third Quarter of 2019 -2.2%
6/21 Form S-8 CAI International, Inc. -1.6%
3/11 CAI International Inc (NYSE: CAI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. -17.1%
8/7 Form 10-Q CAI International, Inc. For: Jun 30 -5.9%
3/4 Form 4 CAI International, Inc. For: Mar 02 Filed by: Cutino Camille -5.8%
2/21 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.7%
3/5 Q4/2019 12/31/2019 EPS 0.540 ZacksConsensus N/A ActVsEst N/A - N/A -3.5%
2/24 Form 4 CAI International, Inc. For: Feb 13 Filed by: PAGE TIMOTHY B -3.4%
5/31 CAI International Inc (NYSE: CAI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -3.3%
10/29 CAI International, Inc. Reports Results for the Third Quarter of 2019 -2.2%
6/21 Form S-8 CAI International, Inc. -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: